Page 25 - 中国全科医学2022-05
P. 25
·534· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn
DA 时,不能只考虑网页版等价廉的方式,应该综合考 HUANG R C,YANG X Y,SONG X T,et al. The current status
虑冠心病人群的特点,设计出患者接受度高的 DA。 and expectation of shared-decision making in Chinese patients with
cardiolvascular diseases[J]. Med Philos(B),2017,38(10):1-6.
4 结论
[9]HIGGINS J P T,SAVOVIC J,PAGE M J,et al. Chapter 8:
SDM 可以被认为是在循证医学证据下、以人文科学 Assessing risk of bias in a randomized trial[S]//HIGGINS J
为指导的个性化治疗。在冠心病诊疗中 DA 的干预效果 P T,THOMAS J,CHANDLER J,et al. Cochrane Handbook
并不明显,但其在临床应用中也具有广阔前景,未来需 for Systematic Reviews of Interventions version 6.1 (updated
要更多的研究来验证其应用效果。要客观看待 DA 的地 September 2020). Cochrane,2020. http:www.training.cochrane.
org/handbook.
位和作用,将医生和患者共同纳入到 SDM 的研究和应用
[10]刘括,孙殿钦,廖星,等 . 随机对照试验偏倚风险评估工具 2.0
过程中。在设计 DA 时,应充分考虑受益人群特征,同 修订版解读[J]. 中国循证心血管医学杂志,2019,11(3):
时将对医生的培训纳入其中,促进 DA 在临床实践落地。 284-291.
本研究纳入文献的受试者均为国外居民,个人价值 LIU K,SUN D Q,LIAO X,et al. Bias risk review tool(2.0
revision) for randomized controlled trials[J]. Chin J Evid -
观、家庭背景、经济条件、社会支持、文化习俗等均与
Based Cardiovasc Med,2019,11(3):284-291.
我国居民不尽相同,在实施 SDM 和 DA 时,应充分考 [11]MORGAN M W,DEBER R B,LLEWELLYN-THOMAS H A,
虑国内人群的特点,设计出符合我国患者需求的工具。 et al. Randomized,controlled trial of an interactive videodisc
目前可查及两项正在中国开展的大型 DA 干预效果评价 decision aid for patients with ischemic heart disease[J]. J Gen
的试验,期待为中国 SDM 的实践带来可喜的结果 [31-32] 。 Intern Med,2000,15(10):685-693. DOI:10.1046/j.1525-
1497.2000.91139.x.
作者贡献:高川进行研究设计、实施、资料收集与
[12]HESS E P,KNOEDLER M A,SHAH N D,et al. The chest pain
整理、撰写论文并对文章负责;高莹进行研究实施、论 choice decision aid:a randomized trial[J]. Circ Cardiovasc Qual
文修改和审校;周俞余进行资料收集与整理、论文修改; Outcomes,2012,5(3):251-259. DOI:10.1161/CIRCOUTC
郭旭芳进行资料收集与整理、论文修改;何仲进行研究 OMES.111.964791.
[13]COYLEWRIGHT M,DICK S,ZMOLEK B,et al. PCI choice
设计、论文修改和审校。
decision aid for stable coronary artery disease:a randomized
本文无利益冲突。 trial[J]. Circ Cardiovasc Qual Outcomes,2016,9(6):767-
参考文献 776. DOI:10.1161/circoutcomes.116.002641.
[1]SPATZ E S,KRUMHOLZ H M,MOULTON B W. Prime time for [14]HESS E P,HOLLANDER J E,SCHAFFER J T,et al. Shared
shared decision making[J]. JAMA,2017,317(13):1309- decision making in patients with low risk chest pain:prospective
1310. DOI:10.1001/jama.2017.0616. randomized pragmatic trial[J]. BMJ,2016:i6165. DOI:
[2]LÉGARÉ F,ADEKPEDJOU R,STACEY D,et al. Interventions 10.1136/bmj.i6165.
for increasing the use of shared decision making by healthcare [15]CASE B C,QAMER S Z,GATES E M,et al. Shared decision
professionals[J]. Cochrane Database Syst Rev,2018,7: making in cardiovascular disease in the outpatient setting[J].
CD006732. DOI:10.1002/14651858.cd006732.pub4. JACC Case Rep,2019,1(2):261-270. DOI:10.1016/j.
[3]KUNNEMAN M,MONTORI V M,CASTANEDA-GUARDERAS A, jaccas.2019.06.005.
et al. What is shared decision making? (and what it is not)[J]. [16]DOLL J A,JONES W S,LOKHNYGINA Y,et al. PREPARED
Acad Emerg Med,2016,23(12):1320-1324. DOI: study:a study of shared decision-making for coronary artery
10.1111/acem.13065. disease[J]. Circ Cardiovasc Qual Outcomes,2019,12(2):
[4]O'CONNOR A M,LLEWELLYN-THOMAS H A,FLOOD A B. e005244. DOI:10.1161/circoutcomes.118.005244.
Modifying unwarranted variations in health care:shared decision [17]STACEY D,LÉGARÉ F,BOLAND L,et al. 20th anniversary
making using patient decision aids[J]. Health Aff:Millwood, Ottawa decision support framework:part 3 overview of systematic
2004(Suppl Variation):VAR63-VAR72. DOI:10.1377/hlthaff. reviews and updated framework[J]. Med Decis Making,2020,
var.63. 40(3):379-398. DOI:10.1177/0272989X20911870.
[5]O'CONNOR A M,BENNETT C,STACEY D,et al. Do patient [18]ELWYN G,O'CONNOR A,STACEY D,et al. Developing
decision aids meet effectiveness criteria of the international patient a quality criteria framework for patient decision aids:online
decision aid standards collaboration? A systematic review and meta- international Delphi consensus process[J]. BMJ,2006,333
analysis[J]. Med Decis Making,2007,27(5):554-574. (7565):417. DOI:10.1136/bmj.38926.629329.ae.
DOI:10.1177/0272989x07307319. [19]SALZBURG GLOBAL SEMINAR. Salzburg statement on shared
[6]国家心血管病中心.中国心血管健康与疾病报告2019[M]. 北京: decision making[J]. BMJ,2011,342:d1745. DOI:
科学出版社,2020. 10.1136/bmj.d1745.
[7]郭伟,张东凤,黄榕翀,等 . 运用医患共同决策模式改善冠心 [20]HOFFMANN T C,MONTORI V M,DEL MAR C. The
病治疗现状[J]. 中国循证心血管医学杂志,2015,7(4): connection between evidence-based medicine and shared decision
572-574. DOI:10.3969/j.1674-4055.2015.04.50. making[J]. JAMA,2014,312(13):1295-1296. DOI:
[8]黄榕翀,杨雪瑶,宋现涛,等 . 中国医患共同决策心血管病领 10.1001/jama.2014.10186.
域研究现状与展望[J]. 医学与哲学(B),2017,38(10):1-6.
(下转第 541 页)